Literature DB >> 12213698

Greater depression severity associated with less improvement in depression-associated cognitive deficits in older subjects.

Warren D Taylor1, H Ryan Wagner, David C Steffens.   

Abstract

OBJECTIVES: Elderly depressed patients often exhibit cognitive deficits, which may improve with drug therapy. The authors investigated the relationship of baseline depression severity and cognitive improvement with antidepressant treatment in depressed patients with mild cognitive impairment.
METHODS: Mini-Mental State Exam (MMSE) and Montgomery-Asberg Depression Rating Scale (MADRS) scores were measured in 52 depressed geriatric patients without dementia at baseline, 6, and 12 months, during an intent-to-treat period. A repeated-measures regression model tested the effect of MADRS score on MMSE.
RESULTS: MMSE changes were significant and linear over time, with an average increase of 0.72 in the MMSE per 6-month interval. The final model showed that for every point increase in baseline MADRS, the average 6-month increase in MMSE decreased by 0.12. Repeated MADRS measurements did not significantly alter its predictive value.
CONCLUSION: Greater baseline depression severity in older subjects with mild cognitive deficits is associated with less improvement in those deficits even with successful antidepressant therapy.

Entities:  

Mesh:

Year:  2002        PMID: 12213698

Source DB:  PubMed          Journal:  Am J Geriatr Psychiatry        ISSN: 1064-7481            Impact factor:   4.105


  5 in total

Review 1.  Nicotine and networks: Potential for enhancement of mood and cognition in late-life depression.

Authors:  Jason A Gandelman; Paul Newhouse; Warren D Taylor
Journal:  Neurosci Biobehav Rev       Date:  2017-08-30       Impact factor: 8.989

2.  Donepezil treatment of older adults with cognitive impairment and depression (DOTCODE study): clinical rationale and design.

Authors:  Gregory H Pelton; Howard Andrews; Steven P Roose; Sue M Marcus; Kristina D'Antonio; Hala Husn; Jeffrey R Petrella; Anthony S Zannas; P Murali Doraiswamy; D P Devanand
Journal:  Contemp Clin Trials       Date:  2013-12-05       Impact factor: 2.226

Review 3.  Cognition as a therapeutic target in late-life depression: potential for nicotinic therapeutics.

Authors:  Lilia Zurkovsky; Warren D Taylor; Paul A Newhouse
Journal:  Biochem Pharmacol       Date:  2013-08-08       Impact factor: 5.858

4.  Randomized double-blind placebo-controlled donepezil augmentation in antidepressant-treated elderly patients with depression and cognitive impairment: a pilot study.

Authors:  Gregory H Pelton; Oliver L Harper; Matthias H Tabert; Harold A Sackeim; Nikolaos Scarmeas; Steven P Roose; D P Devanand
Journal:  Int J Geriatr Psychiatry       Date:  2008-07       Impact factor: 3.485

5.  Accelerated brain aging predicts impaired cognitive performance and greater disability in geriatric but not midlife adult depression.

Authors:  Seth Christman; Camilo Bermudez; Lingyan Hao; Bennett A Landman; Brian Boyd; Kimberly Albert; Neil Woodward; Sepideh Shokouhi; Jennifer Vega; Patricia Andrews; Warren D Taylor
Journal:  Transl Psychiatry       Date:  2020-09-18       Impact factor: 6.222

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.